Company Overview: Nephros

Industry News

10 Jul

Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance

RIVER EDGE, NJ–(Marketwired – Jul 10, 2017) –  Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage...

Read more

9 Jun

Nephros to Present at Marcum 2017 MicroCap Conference

RIVER EDGE, NJ–(Marketwired – Jun 9, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

9 May

Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update

RIVER EDGE, NJ–(Marketwired – May 9, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

24 Apr

Nephros Announces Partnership with WorldWater & Solar Technologies

RIVER EDGE, NJ–(Marketwired – Apr 24, 2017) –  Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to...

Read more

28 Mar

SeeThruEquity Issues Update on Nephros, Inc. (NEPH)

NEW YORK, NY / ACCESSWIRE / March 28, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Nephros, Inc. (NEPH). The report is available here: NEPH Update Note. Based in River...

Read more

17 Mar

Nephros Announces $1.2 Million Private Placement

RIVER EDGE, NJ–(Marketwired – Mar 17, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

6 Mar

Nephros Receives FDA 510(k) Clearance of EndoPur(TM) Endotoxin 10″ Filter

RIVER EDGE, NJ–(Marketwired – Mar 6, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (“HDF”) system for use with a hemodialysis machine for the treatment of...

Read more

14 Feb

Nephros Announces Appointment of Andrew Astor as Chief Financial Officer

RIVER EDGE, NJ–(Marketwired – Feb 14, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

Page 1 of 512345

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address